Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 1
Submit an article Journal homepage
100
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Donor Lymphocyte Infusions for Patients who Relapse After Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukaemia

Maria H. Gilleece Department of Haematology and Immunology, Imperial College Faculty of Medicine, Hammersmith Hospital, London, UK
&
Francesco Dazzi Department of Haematology and Immunology, Imperial College Faculty of Medicine, Hammersmith Hospital, London, UK
Pages 23-28 | Published online: 01 Jul 2009

  • Kolb, H.J., et al. (1990) "Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients", Blood 76(12), 2462-2465.
  • Kolb, H.J., et al. (1995) "Graft-versus-leukemia effects of donor lymphocyte transfusion in marrow grafted patients. European Group for Blood and Marrow transplantation Working Party Chronic Leukemia", Blood 86(5), 2041-2050.
  • Cullis, J.O., et al. (1992) "Donor leukocyte infusions for chronic myeloid leukemia in ralapse after allgeneic bone marrow transplantation", Blood 79(5), 1379-1381.
  • Drobyski, W.R., et al. (1993) "Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-Cell dose", Blood 82(8), 2310-2318.
  • van Rhee, F., et al. (1994) "Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusion before the onset of hematologic relapse", Blood 83(11), 3377-3383.
  • Porter, D.L., et al. (1994) "Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia", N. Engl. J. Med. 330(2), 100-106.
  • Mackinnon, S., et al. (1995) "Adoptive immunotherapy evaluating escalating does of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease", Blood 86(4), 1261-1268.
  • Bar, B. M., et al. (1993) "Donor Leukocyte infusions chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation", J. Clin. Oncol. 11(3), 513-519.
  • Collins, Jr., R.H., et al. (1997) "Donor leukocyte infusions in 140 patients with relapsed malignancy after malignancy after allogeneic bone marrow transplantation", J. Clin. Oncol. 15(2), 433-444.
  • Sehn, L.H., et al. (1999) "Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion", J. Clin. Oncol. 17(2), 561-568.
  • Aversa, F., et al. (1998) "Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotye", N. Engl. J. Med. 339(17), 1186-1193.
  • Moscovitch, M. and Slavin, S. (1984) "Anti-tumor-effects of allogeneic bone marrow transplantation in (NZB XNZW)F1 hybrids with spontaneous lymphosarcoma", J. Immunol. 132(2), 997-1000.
  • Wallny, H.J. and Rammensee, H.G. (1990) "Identification of classical minor histocompatibility antigen as cell-derived peptide", Nature 343(6255), 275-278.
  • Goulmy, E., et al. (1996) "Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation", N. Engl. J. Med. 334(5), 281-285.
  • Warren, E.H., Greenberg, D.P. and Riddell, S.R. (1998) "Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution", Blood 91(6), 2197-2207.
  • Faber, L.M., et al. (1995) "Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes" J. Clin. Investig. 96(2), 877-883.
  • Marks, D.I., et al. (1992) "HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome", Br. J. haematol. 81(3), 383-390.
  • Clift, R.A., Appelbaum, F.R. and Thomas, E.D. (1993) "Treatment of chronic myeloid leukemia by marrow transplantation", Blood 82(7), 1954-1956.
  • Marks, D.I., et al. (1993) "Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years", Ann. Intern. Med. 119(3), 207-214.
  • Atkinson, K., et al. (1996) "Five year leukaemia-free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation", Aust. N.Z. J. Med. 26(1), 54-58.
  • Hansen, J.A., et al. (1998) "Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia". N. Engl. J. Med. 338(14), 962-968.
  • Apperley, J.F., et al. (1998) "Immunotherapy for chronic myeloid leukaemia", Hematol, Cell Ther. 40(5), 229-232.
  • Goldman, J.M., et al. (1998) "Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion", Ann. Intern. Med. 108(6), 806-814.
  • Marmont, A.M. et al. (1991) "T-cell depletion of HLA-identical transplants in leukemia", Blood 78(8), 2120-2130.
  • Arcese, W., et al. (1993) "Outcome for patients who ralapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group", Blood 82(10), 3211-3219.
  • Cross, N.C. et al. (1993) "Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation", Blood 82(6), 1929-1936.
  • Hochhaus, A., et al. (1996) "Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction", Blood 87(4), 1549-1555.
  • Olavarria, E., et al. (2001) "Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia", Blood 97(6), 1560-1565.
  • Higano, C.S., et al. (1997) "Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation", Blood 90(7), 2549-2554.
  • Pigneux, A., et al. (1995) "Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Societe Francaise de Greffe de Moelle", Bone Marrow Transplant. 15(6), 819-824.
  • Sierra, J., et al. (1997) "Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effects of leukemic burden, donor HLA-matching and marrow cell dose", Blood 89(11), 4226-4235.
  • Apperley, J.F., et al. (1986) "Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse". Bone Marrow Transplant 1(1), 53-66.
  • Cwynarski, K., et al. (2001) "ST1571 inhibits the activation and proliferation of normal T lymphocytes", Blood 98(11), 256b.
  • Drobyski, W.R., et al. (1992) "Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation", Bone Marrow Transplant. 10(3), 301-304.
  • Champlin, R. (1993) "T-cell depletion for allogeneic bone marrow transplantation: impact on graft-versus-host disease, engraftment, and graft-versus-leukemia", J.Hematother, 2(1), 27-42.
  • Helg, C., et al. (1993) "Adoptive immunotherapy for recurrent CML after BMT", Bone Marrow Transplant. 12(2), 125-129.
  • Giralt, S., et al. (1995) "CD-8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogenic bone marrow transplantation", Blood 86(11), 4337-4343.
  • Dazzi, F., et al. (2000) "Durability of responses following donor lymphocyte infusion for patients who relapse after allogenic stem cell transplantation for chronic myeloid leukemia", Blood 96(8), 2712-2716.
  • van Rhee, F., et al. (1988) "Adoptive immunotherpay for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors", Bone Marrow Transplant. 21(10), 1055-1061.
  • Slavin, S., et al. (1996) "Allogeneic cell therapy with donor peripheral blood cells and recombinant humaninteleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation", Blood 87(6), 2195-2204.
  • Dazzi, F., et al. (1998) "Interleukin-2 may induce complete remission in patients who respond only partially to donor lymphocyte infusion (DLI) for relapse following allogeneic bone marrow transplantation", Br. J. Haematol. 102(Suppl.1). 287.
  • Rezvani, K., et al. (2000) "Responses of CML to donor lymphocyte infusion (DLI): factors influencing the effective cell dose and implications for the definition of refractoriness", Blood 92(S), 835.
  • Wu, C.J., et al. (2000) "Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia". J. Clin. Investig. 106(5), 705-714.
  • Smit, W.M., et al. (1998) "T cell recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effects of donor lymphocyte infusion for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation", Proc. Natl Acad. Sci. USA 95 (17), 10152-10157.
  • Godder, K.T., et al. (1998) "Donor leukocyte infusion for treatment of graft rejection post partially mismatched related donor bone marrow transplant", Bone Marrow Transplant, 22(1), 111-113.
  • Raanani, P., et al. (1997) "The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation". Br. J. Haematol. 99(4), 945-950.
  • Baurmann, H., et al. (1998) "Kinetics of the graft-versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation", Blood 92(10), 3582-3590.
  • Craddock, C., et al. (2000) "Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission", Blood 96(1), 86-90.
  • Porter, D.L., et al. (1999) "Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions", Biol. Blood Marrow Transplant. 5(4), 253-261.
  • Alyea, E.P., et al. (1998) "Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant", Blood 91(10), 3671-3680.
  • Montagna, D., et al. (1999) "Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity", Blood 93(10), 3550-3557.
  • Andre-Schmutz, et al. (2001) "Specific depletion of graft-versus-host potential from T cells: immunomagnetic versus immunotoxin strategies", Blood 98(11), 1642.
  • Dazzi, F., et al. (2000) "Comparison of single-dose escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia", Blood 95(1), 67-71.
  • Tiberghien, P., et al. (1994) "Ganiciclovir treatment of herpse simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?" Blood 84(4), 1333-1341.
  • Bonini, C., et al. (1997) "HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia", Science 276(5319), 1719-1724.
  • Bordignon, C., et al. (1995) "Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation". Hum, Gene Ther. 6(6), 813-819.
  • Verzeletti, S., et al. (1998) "Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors", Hum. Gene Ther. 9(15), 2243-2251.
  • Thomis, D.C., et al. (2001) "A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease", Blood 97(5), 1249-1257.
  • Keil, F., et al. (1997) "Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aphlasia", Blood 89(9), 3113-3117.
  • Slavin, S., et al. (1998) "Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic disease", Blood 91(3), 756-763.
  • Khouri, I.F., et al. (1998) "Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignacies". J. Clin. Oncol. 16(8), 2817-2824.
  • Shlomchik, W.D., et al. (1999) "Prevention of graft versus host disease by inactivation of host antigen-presenting cells", Science 385(5426), 412-415.`

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.